PRVA Graph | Privia Health Group, Inc.

PRVA Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

2026-06-30: Revenue including tax $632.63M; Operating expenses $620.86M; Income tax $7.02M; Net income $9.05M.
2026-03-31: Revenue including tax $603.85M; Operating expenses $596.42M; Income tax $5.60M; Net income $3.06M.
2025-12-31: Revenue including tax $541.17M*; Operating expenses $529.89M*; Income tax $2.79M*; Net income $9.15M*.
2025-09-30: Revenue including tax $580.42M; Operating expenses $566.02M; Income tax $6.87M; Net income $6.86M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period end	Revenue including tax	Operating expenses	Income tax	Net income
2026-06-30	$632.63M	$620.86M	$7.02M	$9.05M
2026-03-31	$603.85M	$596.42M	$5.60M	$3.06M
2025-12-31	$541.17M*	$529.89M*	$2.79M*	$9.15M*
2025-09-30	$580.42M	$566.02M	$6.87M	$6.86M
2025-06-30	$521.15M	$517.82M	$2.46M	$2.69M
2025-03-31	$480.10M	$474.88M	$2.10M	$4.22M
2024-09-30	$437.92M	$432.11M	$4.00M	$3.54M
2024-06-30	$422.33M	$417.23M	$3.42M	$3.47M
2024-03-31	$415.24M	$414.42M	$751.00K	$2.98M
2023-09-30	$417.28M	$411.75M	$2.49M	$5.64M
2023-06-30	$413.35M	$406.37M	$1.44M	$7.27M
2023-03-31	$386.28M	$379.56M	$2.13M	$7.32M
2022-09-30	$342.90M	$347.47M	-$4.84M	$1.62M
2022-06-30	$335.54M	$340.79M	$5.47M	-$10.47M
2022-03-31	$313.80M	$325.35M	$6.31M	-$17.51M
2021-09-30	$251.52M	$264.33M	-$2.21M	-$9.12M
2021-06-30	$225.76M	$418.94M	-$20.00M	-$172.53M
2021-03-31	$213.61M	$205.70M	$2.00M	$5.40M
2020-09-30	$207.17M	$198.63M	-$8.56M	$16.68M
2020-06-30	$183.26M	$177.09M	$474.00K	$5.28M
2020-03-31	$212.94M	$206.45M	$700.00K	$5.41M

Revenue and expense 6 month

Period end	Revenue including tax	Operating expenses	Income tax	Net income
2026-06-30	$1.24B	$1.22B	$12.62M	$12.11M
2025-06-30	$1.00B	$992.70M	$4.56M	$6.91M
2024-06-30	$837.57M	$831.65M	$4.17M	$6.45M
2023-06-30	$799.63M	$785.93M	$3.56M	$14.60M
2022-06-30	$649.34M	$666.13M	$11.78M	-$27.98M
2021-06-30	$439.36M	$624.64M	-$18.00M	-$167.14M
2020-06-30	$396.21M	$383.53M	$1.17M	$10.70M

Revenue and expense 9 month

Period end	Revenue including tax	Operating expenses	Income tax	Net income
2025-09-30	$1.58B	$1.56B	$11.43M	$13.77M
2024-09-30	$1.28B	$1.26B	$8.17M	$9.99M
2023-09-30	$1.22B	$1.20B	$6.05M	$20.24M
2022-09-30	$992.24M	$1.01B	$6.93M	-$26.36M
2021-09-30	$690.89M	$888.98M	-$20.21M	-$176.25M
2020-09-30	$603.38M	$582.16M	-$7.39M	$27.38M

Revenue and expense 12 month

Period end	Revenue including tax	Operating expenses	Income tax	Net income
2025-12-31	$2.12B	$2.09B	$14.21M	$22.92M
2024-12-31	$1.74B	$1.72B	$10.83M	$14.38M
2023-12-31	$1.66B	$1.64B	$7.99M	$23.08M
2022-12-31	$1.36B	$1.38B	-$6.52M	-$8.59M
2021-12-31	$966.22M	$1.18B	-$27.86M	-$188.23M
2020-12-31	$817.08M	$791.70M	-$7.44M	$31.24M
2019-12-31	$786.36M	$770.30M	$1.21M	$8.24M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
GeneDx Holdings Corp. (WGS)	United States	$2.638B	-19.23
Pennant Group, Inc. (PNTG)	United States	$1.386B	39.84
U S PHYSICAL THERAPY INC /NV (USPH)	United States	$1.251B	32.48
Omada Health, Inc. (OMDA)	United States	$1.207B	309.08
InnovAge Holding Corp. (INNV)	United States	$1.206B	-635.60
Strata Critical Medical, Inc. (SRTA)	United States	$0.467B	11.33
LifeStance Health Group, Inc. (LFST)	United States	$4.510B	80.86
DocGo Inc. (DCGO)	United States	$0.034B	-0.25
VSEE HEALTH, INC. (VSEE)	United States	$0.003B
Agape ATP Corp (ATPC)		$0.002B